Peder Jensen Insider Profile
4 Followers
Peder Jensen, Director at BioCryst, holds 60.00K shares in BioCryst (Ticker: BCRX), holds 0.00 shares in Acorda Therapeutics (Ticker: ACORQ), holds 0.00 shares in Five Prime Therapeutics (Ticker: FPRX). Most recently, Peder Jensen Bought ― shares of BioCryst on Dec 17, 2012 for an estimated value of $30.20K.
Peder Jensen's Trading History
| BCRXBioCryst | Dec 17, 2012 | Director | Informative Buy | 30.20K | $456.60K | |
| FPRXFive Prime Therapeutics | ― | ― | ― | $0.00 | ||
| ACORQAcorda Therapeutics | ― | ― | ― | $0.00 |
You May Also Like
Peder Jensen insider profile FAQ
What is the percentage of profitable transactions made by Peder Jensen?
The percentage of profitable transactions made by Peder Jensen is 50%.
What is the average return per transaction made by Peder Jensen?
The average return per transaction made by Peder Jensen is 57.60%.
What stocks does Peder Jensen hold?
Peder Jensen holds: BCRX, ACORQ, FPRX stocks.
What was Peder Jensen’s latest transaction?
Peder Jensen’s latest transaction was an Informative Buy of $30.20K.
What was Peder Jensen's most profitable transaction?
Peder Jensen’s most profitable transaction was an Informative Buy of BCRX stock on December 17, 2012. The return on the trade was 323.50%.
What is Peder Jensen's role in BioCryst?
Peder Jensen's role in BioCryst is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
